Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

2008 New England Journal of Medicine 7,291 citations

Abstract

A strategy of intensive glucose control, involving gliclazide (modified release) and other drugs as required, that lowered the glycated hemoglobin value to 6.5% yielded a 10% relative reduction in the combined outcome of major macrovascular and microvascular events, primarily as a consequence of a 21% relative reduction in nephropathy. (ClinicalTrials.gov number, NCT00145925.)

Keywords

MedicineHazard ratioGlycated hemoglobinInternal medicineType 2 diabetesRetinopathyNephropathyDiabetes mellitusDiabetic retinopathyAlbuminuriaIncidence (geometry)Stroke (engine)Confidence intervalEndocrinologyRenal function

Affiliated Institutions

Related Publications

Publication Info

Year
2008
Type
article
Volume
358
Issue
24
Pages
2560-2572
Citations
7291
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

7291
OpenAlex

Cite This

Anushka Patel, Stephen MacMahon, John Chalmers et al. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine , 358 (24) , 2560-2572. https://doi.org/10.1056/nejmoa0802987

Identifiers

DOI
10.1056/nejmoa0802987